✦ LIBER ✦

Compared to tamoxifen, letrozole increases tumor response in post-menopausal women with estrogen-receptor-positive primary breast cancer

✍ Scribed by Visaharan Sivasubramaniam; Gary H. Lyman

Book ID: 114483831
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 77 KB
Volume: 3
Category: Article
ISSN: 1363-4054
DOI: 10.1054/ebon.2001.0175

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Compared to tamoxifen, letrozole increas

Compared to tamoxifen, letrozole increases tumor response in post-menopausal women with advanced breast cancer

✍ Visaharan Sivasubramaniam; Gary H. Lyman 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Pharmacoeconomic analysis of adjuvant th

Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer

✍ Juan Miguel Gil; Carlos Rubio-Terrés; Almudena del Castillo; Paloma González; Fe 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 827 KB

Locally advanced breast cancer: long-ter

Locally advanced breast cancer: long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal women

✍ P.C. Willsher; J.F.R. Robertson; N.C. Armitage; D.A.L. Morgan; R.I. Nicholson; R 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 367 KB

Gene expression profiling of response to

Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer

✍ Vicky S. Sabine; Andrew H. Sims; E. Jane Macaskill; Lorna Renshaw; Jeremy S. Tho 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 566 KB

BOLERO-2: Everolimus in combination with

BOLERO-2: Everolimus in combination with exemestane in the treatment of postmenopausal women with estrogen receptor-positive ADVANCED breast cancer refractory to letrozole or anastrozole

✍ Mario Campone; Martine Piccart; Kathleen I. Pritchard; Cindy Xu; Michael Gnant; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Comparison of anastrozole versus tamoxif

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial

✍ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract ## BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0‐2, M0), or potentially operable (T4b, N0‐2, M0) br